Reason for request
Inclusion on the list of medicines refundable by National Health Insurance and approved for hospital use.
Clinical Benefit
| Low |
The actual benefit of BRONCHITOL is low. |
Clinical Added Value
| no clinical added value |
BRONCHITOL does not offer any improvement in actual benefit (IAB V) in the management of adult patients aged 18 and over with cystic fibrosis. |
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
4BawWKQ0tPL54B9R
Listen
